Pharmacogenetics initiative galvanizes public and private sectors

Pharmacogenetics initiative galvanizes public and private sectors

Play all audios:

Loading...

Skills in genetics and clinical research are in demand as academia and industry try to tailor treatments to their patients, says Paul Smaglik. Access through your institution Buy or


subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online


access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which


are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support AUTHOR INFORMATION AUTHORS AND


AFFILIATIONS * editor of Naturejobs, Paul Smaglik Authors * Paul Smaglik View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints


and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Smaglik, P. Pharmacogenetics initiative galvanizes public and private sectors. _Nature_ 410, 393–394 (2001).


https://doi.org/10.1038/35066732 Download citation * Issue Date: 15 March 2001 * DOI: https://doi.org/10.1038/35066732 SHARE THIS ARTICLE Anyone you share the following link with will be


able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing


initiative